Get the Stockscreener App
0.92
3.36%
0.0299
Evaxion Biotech A S Adr Stock (EVAX) Forecast
The Evaxion Biotech A S Adr (EVAX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.05, representing a +1,536% increase from the current price of $0.92. The highest analyst price target is $27.89, and the lowest is $2.2109.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVAX Price Target
Average 90.50
(+9,737% Upside)
Is Evaxion Biotech A S Adr (EVAX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.53 | Buy |
| STOCH(9,6) | 9.6815 | Buy |
| STOCHRSI(14) | 25.26 | Neutral |
| MACD(12,26) | -0.29 | Sell |
| ADX(14) | 30.91 | Sell |
| William %R | -90.19 | Buy |
| CCI(14) | -81.00 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0936
Sell
|
1.0743
Sell
|
| MA20 |
1.2958
Sell
|
1.2868
Sell
|
| MA50 |
1.9479
Sell
|
1.7967
Sell
|
| MA100 |
2.468
Sell
|
2.3134
Sell
|
| MA200 |
2.9466
Sell
|
3.3307
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EVAX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on EVAX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.53 indicates that EVAX is oversold. This indicates that EVAX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 9.6815 indicates that EVAX is oversold. This indicates that EVAX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25.26 indicates that EVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.91 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -81 indicates that EVAX is still oversold but not to an extreme extent.
Long-term EVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Evaxion Biotech A S Adr financial reports and earnings history, Evaxion Biotech A S Adr (EVAX) stock could reach $61.00 by 2030, $287.08 by 2040 and $37.37 by 2050. See the projected annual prices until 2050 of the Evaxion Biotech A S Adr stock below:
- Evaxion Biotech A S Adr (EVAX) is expected to reach an average price of $27.89 in 2035, with a high prediction of $29.24 and a low estimate of $28.26. This indicates an $2,931% rise from the last recorded price of $0.92.
- Evaxion Biotech A S Adr (EVAX) stock is projected to chart a bullish course in 2040, with an average price target of $282.10, representing an $30,563% surge from its current level. The forecast ranges from a conservative $282.70 to a sky-high $287.08.
- Our analysts predict Evaxion Biotech A S Adr (EVAX) to jump 20,961% by 2045, soaring from $194.36 to an average price of $193.76, potentially reaching $197.52. While $194.36 is the low estimate, the potential upside is significant.
- Evaxion Biotech A S Adr (EVAX) stock is expected to climb by 2050, reaching an average of $28.17, a $2,962% jump from its current level. However, a wide range of estimates exists, with high and low targets of $37.37 and $28.28, respectively, highlighting the market's uncertainty.
Evaxion Biotech A S Adr Stock (EVAX) Year by Year Forecast
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2025
Evaxion Biotech A S Adr Stock (EVAX) is expected to reach an average price of $90.50 in 2025, with a high prediction of $180.92 and a low estimate of $0.0788. This indicates an +9,737% rise from the last recorded price of $0.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $14.46 | $2.2109 | $27.89 | +1,472% |
| February, 2025 | $0.7171 | $0.0788 | $180.92 | -22.06% |
| March, 2025 | $21.13 | $9.0447 | $19.23 | +2,197% |
| April, 2025 | $21.34 | $24.43 | $21.42 | +2,219% |
| May, 2025 | $33.59 | $22.30 | $27.39 | +3,551% |
| June, 2025 | $31.93 | $32.73 | $31.25 | +3,371% |
| July, 2025 | $30.94 | $32.16 | $30.76 | +3,263% |
| August, 2025 | $28.59 | $28.96 | $28.03 | +3,007% |
| September, 2025 | $28.64 | $29.77 | $26.94 | +3,013% |
| October, 2025 | $35.64 | $35.68 | $35.96 | +3,774% |
| November, 2025 | $33.19 | $34.29 | $34.27 | +3,508% |
| December, 2025 | $19.60 | $25.70 | $31.95 | +2,030% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2026
The predicted value for Evaxion Biotech A S Adr (EVAX) in 2026 is set at an average of $19.13. Estimates vary from a peak of $24.17 to a trough of $14.09, indicating an +1,979% surge from the present price of $0.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $23.75 | $21.17 | $18.88 | +2,481% |
| February, 2026 | $26.09 | $26.69 | $24.17 | +2,736% |
| March, 2026 | $15.74 | $18.94 | $16.62 | +1,611% |
| April, 2026 | $19.45 | $16.60 | $18.25 | +2,014% |
| May, 2026 | $18.80 | $19.60 | $18.67 | +1,943% |
| June, 2026 | $21.49 | $21.56 | $20.68 | +2,236% |
| July, 2026 | $20.95 | $21.45 | $21.67 | +2,177% |
| August, 2026 | $20.00 | $20.50 | $19.20 | +2,074% |
| September, 2026 | $20.71 | $20.06 | $21.95 | +2,151% |
| October, 2026 | $16.55 | $18.25 | $20.17 | +1,699% |
| November, 2026 | $12.20 | $14.59 | $16.58 | +1,226% |
| December, 2026 | $14.31 | $14.09 | $13.81 | +1,455% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Evaxion Biotech A S Adr (EVAX) is $7.0412, with a high forecast of $13.52 and a low forecast of $0.5609. This indicates an +665.34% increase from the last price of $0.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.06 | $13.36 | $13.52 | +1,319% |
| February, 2027 | $12.00 | $12.14 | $12.12 | +1,205% |
| March, 2027 | $13.60 | $13.71 | $13.11 | +1,378% |
| April, 2027 | $11.63 | $13.16 | $12.83 | +1,164% |
| May, 2027 | $10.21 | $10.84 | $10.72 | +1,009% |
| June, 2027 | $7.4158 | $7.3296 | $8.5931 | +706.07% |
| July, 2027 | $7.6618 | $7.4183 | $7.2628 | +732.80% |
| August, 2027 | $4.5187 | $5.6717 | $6.7235 | +391.17% |
| September, 2027 | $6.2974 | $5.5705 | $5.5774 | +584.50% |
| October, 2027 | $5.1744 | $5.1827 | $5.1392 | +462.43% |
| November, 2027 | $3.6113 | $3.9113 | $4.5511 | +292.53% |
| December, 2027 | $0.45 | $0.5609 | $2.174 | -51.09% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2028
In 2028, Evaxion Biotech A S Adr (EVAX) is projected to reach an average price of $55.85, with a high projection of $111.43 and a low estimate of $0.2717. This indicates an +5,971% rise from the last price of $0.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $104.23 | $0.2717 | $87.95 | +11,229% |
| February, 2028 | $110.22 | $98.50 | $95.15 | +11,881% |
| March, 2028 | $96.84 | $105.24 | $107.96 | +10,426% |
| April, 2028 | $94.03 | $96.76 | $95.85 | +10,121% |
| May, 2028 | $85.75 | $95.38 | $89.23 | +9,221% |
| June, 2028 | $98.74 | $84.39 | $88.74 | +10,633% |
| July, 2028 | $93.14 | $95.84 | $93.99 | +10,024% |
| August, 2028 | $53.75 | $64.85 | $90.36 | +5,743% |
| September, 2028 | $51.14 | $53.10 | $50.18 | +5,458% |
| October, 2028 | $64.64 | $60.47 | $57.72 | +6,926% |
| November, 2028 | $88.86 | $78.09 | $111.43 | +9,559% |
| December, 2028 | $90.45 | $92.85 | $87.83 | +9,732% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2029
The 2029 price forecast for Evaxion Biotech A S Adr Stock (EVAX) is $77.85 on average, with a high prediction of $94.59 and a low estimate of $61.10. This represents an +8,362% increase from the previous price of $0.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $97.37 | $87.40 | $91.17 | +10,484% |
| February, 2029 | $93.96 | $94.76 | $94.59 | +10,114% |
| March, 2029 | $93.16 | $93.31 | $91.91 | +10,026% |
| April, 2029 | $86.75 | $87.55 | $89.88 | +9,330% |
| May, 2029 | $84.97 | $86.55 | $84.98 | +9,136% |
| June, 2029 | $89.56 | $90.26 | $91.42 | +9,635% |
| July, 2029 | $86.96 | $88.96 | $88.29 | +9,352% |
| August, 2029 | $75.48 | $77.58 | $84.43 | +8,104% |
| September, 2029 | $69.17 | $70.06 | $68.60 | +7,418% |
| October, 2029 | $72.79 | $72.39 | $71.74 | +7,812% |
| November, 2029 | $60.68 | $63.88 | $62.43 | +6,496% |
| December, 2029 | $62.07 | $61.10 | $60.35 | +6,647% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2030
Evaxion Biotech A S Adr Stock (EVAX) is expected to reach an average price of $48.16 in 2030, with a high forecast of $61.00 and a low forecast of $35.33. This signifies an +5,135% surge from the last price of $0.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $59.79 | $60.59 | $61.00 | +6,399% |
| February, 2030 | $60.74 | $61.58 | $60.36 | +6,502% |
| March, 2030 | $58.88 | $59.88 | $60.03 | +6,300% |
| April, 2030 | $55.79 | $56.42 | $57.60 | +5,964% |
| May, 2030 | $56.79 | $54.92 | $55.49 | +6,073% |
| June, 2030 | $47.98 | $52.68 | $52.84 | +5,116% |
| July, 2030 | $41.80 | $44.19 | $47.06 | +4,444% |
| August, 2030 | $42.70 | $42.37 | $41.15 | +4,541% |
| September, 2030 | $39.29 | $40.09 | $41.22 | +4,171% |
| October, 2030 | $35.91 | $36.31 | $37.77 | +3,803% |
| November, 2030 | $36.00 | $36.48 | $35.38 | +3,813% |
| December, 2030 | $33.12 | $35.33 | $34.82 | +3,501% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):